Prognostic value of DNA alterations on chromosome 17p13.2 for intrahepatic cholangiocarcinoma

Table 2 Clinocopathological parameters and allelic loss of the target fragment (518 bp) on chromosome 17p13.2 in ICC patients

Parameters	Allelic loss		P	OR (95% CI)
	+	-
	n (%)	n (%)
Age (yr)			0.456
≤ 50	3 (18.8)	13 (81.3)		1.00 (referent)
> 50	4 (11.1)	32 (88.9)		0.54 (0.11-2.76)
Gender			0.721
Male	6 (14.3)	36 (85.7)		1.00 (referent)
Female	1 (10.0)	9 (90.0)		0.67 (0.07-6.26)
Histological type			0.726
Well-differentiated	6 (25.0)	18 (75.0)		1.00 (referent)
Moderately differentiated	6 (42.85)	8 (57.15)		2.25 (0.45-11.62)
Poorly differentiated	3 (27.27)	8 (72.73)		1.13 (0.17-7.25)
Tumor size (cm)			0.63
≤ 7	2 (13.3)	13 (86.7)		1.00 (referent)
> 7	1 (7.7)	12 (92.3)		0.54 (0.04-6.77)
Metastasis			0.447
Positive	5 (14.3)	30 (85.7)		2.33 (0.22-57.93)
Negative	1 (6.7)	14 (93.3)		1.00 (referent)
Lymph node metastasis			0.737
Positive	2 (13.3)	13 (86.7)		1.38 (0.14-12.27)
Negative	3 (10.0)	27 (90.0)		1.00 (referent)